Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Medicine » Cardiovascular Disorders » Percutaneous Valve Technology: Present and Future Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Doxycycline: Medical Uses and Effects
$82.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Percutaneous valve Technology University of Leipzig experience Present and future perspectives (pp. 473-490)
Tell A Friend
 
Tell someone you know about this product.
Percutaneous valve Technology University of Leipzig experience Present and future perspectives (pp. 473-490) $100.00
Authors:  (David M. Holzhey, Martin Haensig, Friedrich W. Mohr, Ardawan J. Rastan)
Abstract:
Since the first transcatheter aortic valve implantation (TAVI) by Alain Cribier in the year 2002 a rapid evolution of the catheter-based therapy to treat severe symptomatic aortic valve stenosis in risk patients has taken place and transapical as well as transfemoral aortic valve implantation has become a routine procedure at many centers [1,16-20]. These new therapeutic approaches for formerly inoperable or very high risk patients have reduced the threshold for treating aortic valve disease far towards higher age and acceptance of significant comorbidities [10]. In parallel, transcatheter technologies have sensitized not only cardiologist but also internal and home doctors to offer these alternative techniques to their old patients with symptomatic aortic stenosis for whom they in former years would have accepted soon death as a natural course. This had led to a significant increase of TAVI procedures worldwide.
Recent studies showed a clear benefit of survival for patients receiving aortic valve implantation compared to optimal medical therapy including aortic valvuloplasty [10,14,21]. These results gave a further boost for both industry and treating physicians to get even more involved in this relatively young field. However, results of TAVI are far from perfect and several questions had to be answered to improve results in the future. One major issue is the right indication for a TAVI and if, whether it should be performed transapically or transfemorally [3]. Second is how to reduce present technical limitations like a high rate of atrioventricular block, a high rate of (minimal to severe) paravalvular leaks and a comparably high rate of at least minor strokes [10,14,21,22]. Whether these drawbacks will influence long term results and quality of life remains unclear at the present state. In this chapter we aim to
summarize our five year experience with TAVI starting with our program in 2006 and to describe lessons we have learned and improvement that were made over the time. Finally we would give some perspectives for the future, especially on new devices which eventually overcome some of the current device limitations. 


Available Options:
Version:
This Item Is Currently Unavailable.
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2019

Percutaneous valve Technology University of Leipzig experience Present and future perspectives (pp. 473-490)